Overview
The Labsystems Diagnostics Neonatal 17OH Progesterone FEIA is a competitive fluorometric enzyme immunoassay designed for the quantitative determination of 17-hydroxyprogesterone from dried blood spot samples. The test accurately identifies 21-hydroxylase deficiency, the most common form of CAH, enabling timely and effective newborn screening.
Features
- Quantitative fluorometric enzyme immunoassay for 17OH-progesterone
- Uses dried blood spot samples for minimal invasiveness
- Measures 21-hydroxylase deficiency, covering over 90% of CAH cases
- Competitive assay ensuring precise quantification
- High reproducibility and reliability for clinical decision-making
- Calibrated against the latest international reference standards
Technical Specifications
- Format : 10 solid plates (96 wells each)
- Total Wells : 960
- Catalogue Number : 6199871
Benefits
- Excellent Reproducibility : Consistent results across multiple tests
- High Sensitivity : Optimized signal-to-background ratio for accurate detection
- International Calibration : Aligned with the latest global reference standards
Inquiry Form